Trials / Unknown
UnknownNCT02816944
Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory Neoplasms
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- First Affiliated Hospital of Zhejiang University · Academic / Other
- Sex
- All
- Age
- 18 Years – 100 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the safety and efficacy of endoscopic ultrasonography (EUS) guided laser ablation liver, pancreas, and retroperitoneal tumors, the investigators used preoperative and postoperative US/CEUS/CT/MRI to assess lesions, and laboratory tests including the tumor markers to evaluate the general condition of patients. Intraoperative US/CEUS/CT would be applied to monitor ablation lesions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | EUS-guided laser ablation for refractory neoplasms |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2018-06-01
- Completion
- 2018-06-01
- First posted
- 2016-06-29
- Last updated
- 2016-06-30
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02816944. Inclusion in this directory is not an endorsement.